Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value?
about
Clinical proton MR spectroscopy in central nervous system disordersEfficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making.Applications of magnetic resonance spectroscopy in radiotherapy treatment planning.Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.A metabolomics perspective of human brain tumours.Chemical shift-based water/fat separation: a comparison of signal models.In vivo characterization of several rodent glioma models by 1H MRSInhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1H magnetic resonance spectroscopy, post-processing and metabolite quantification at 14.1 T.Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.Lipid metabolism impairment in human gliomas: expression of peroxisomal proteins in human gliomas at different grades of malignancy.Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours.
P2860
Q30764446-AE99CC40-C639-4B78-A89E-77E8898F0127Q30989929-A16CDE93-BBDF-4C4B-8194-1C3B210279A6Q31061313-536A2722-D196-4700-8F39-D1C3F09E2FB9Q31144824-EC795BD1-310C-4E19-A544-63842F6DCB41Q33273666-5D9F582E-61CE-4282-A1F1-61F49BD0B90CQ33622591-B4AEFDFF-7ACF-4568-9CB9-FDDD7BD59D09Q34033507-546C1625-428C-4FC0-B3C5-9EFA894211D6Q35738941-9122B6EE-D29E-4D06-A932-609CE9262F26Q36575246-7FB37C09-0E65-4450-9780-4AAE9110197CQ41931195-521596E5-E6DB-469A-A928-F5B8E935D485Q44916216-2CC525DB-09BD-4234-8DCB-DF73786AC794Q46502407-3137E496-2457-4C63-9FEC-D65F73DBBCB3Q50581029-AC5C002B-CFBD-4B99-9113-179E974BC4EEQ54935926-A99D5D7C-E360-4BDE-9CF6-AFB07796D08B
P2860
Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Could assessment of glioma met ...... (1)H-MRS be of clinical value?
@ast
Could assessment of glioma met ...... (1)H-MRS be of clinical value?
@en
type
label
Could assessment of glioma met ...... (1)H-MRS be of clinical value?
@ast
Could assessment of glioma met ...... (1)H-MRS be of clinical value?
@en
prefLabel
Could assessment of glioma met ...... (1)H-MRS be of clinical value?
@ast
Could assessment of glioma met ...... (1)H-MRS be of clinical value?
@en
P2093
P2860
P356
P1476
Could assessment of glioma met ...... (1)H-MRS be of clinical value?
@en
P2093
Dzik-Jurasz AS
Rowland IJ
P2860
P304
P356
10.1259/BJR/16316438
P407
P50
P577
2003-07-01T00:00:00Z